Случай SAPHO-синдрома – диагностический путь и опыт успешного применения памидроната


П.И. Новиков, Е.А. Макаров, А.С. Зыкова, С.В. Моисеев

ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва
Синдром SAPHO – крайне редкое заболевание с неясной этиологией, поражающее опорно-двигательный аппарат с формированием остеитов и гиперостозов, а также кожные покровы. Его место в классификации ревматологических болезней требует уточнения, как и алгоритм терапии. В статье представлено клиническое наблюдение с обзором литературы.

Литература


1. Aljuhani F., Tournadre A., Tatar Z., Couderc M., Mathieu S., Malochet-Guinamand S., Soubrier M., Dubost J. J. The SAPHO syndrome: a single-center study of 41 adult patients. J. Rheumatol. 2015;42:2:329–34.

2. Hayem G., Bouchaud-Chabot A., Benali K., Roux S., Palazzo E., Silbermann-Hoffman O., Kahn M.F., Meyer O. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin. Arthritis Rheum. 1999;29(3):159–71.

3. Rohekar G., Inman R.D. Conundrums in nosology: synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome and spondylarthritis. Arthritis Rheum. 2006;55(4):665–69.

4. Earwaker J.W., Cotten A. SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol. 2003;32(6):311–27.

5. McGonagle D., McDermott M.F. A Proposed Classification of the Immunological Diseases. PLoS Medicine. 2006;3(8):e297.

6. Бочкова А.Г., Братыгина Е.А., Тюхова Е.Ю., Бунчук Н.В. Синдром SAPHO: описание двух клинических наблюдений. Научно-практич. ревматология. 2009;47(5)77–82.

7. Benhamou C.L., Chamot A.M., Kahn M.F. Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin. Exp. Rheumatol. 1988;6(2):109–12.

8. Li C., Zuo Y., Wu N., Li L., Li F., Zhang W., Xu W., Zhao X., Jing H., Pan Q., Zhou W., Shi X., Fan Y., Wang J., Liu S., Liu Z., Zhang F., Zeng X., Chen H., Zhang S., Liu J., Qiu G., Wu Z., Dong Z., Zhang W. Synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a single centre study of a cohort of 164 patients. Rheumatology (Oxford). 2016;55(6):1023–30.

9. Nguyen M.T., Borchers A., Selmi C., Naguwa S.M., Cheema G., Gershwin M.E. The SAPHO syndrome. Semin. Arthritis Rheum. 2012;42(3):254–65.

10. Boutin R.D., Resnick D. The SAPHO syndrome: an evolving concept for unifying several idiopathic disorders of bone and skin. AJR. Am. J. Roentgenol. 1998;170(3):585–91.

11. Schaub S., Sirkis H. M., Kay J. Imaging for Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome. Rheum. Dis. Clin. North. Am. 2016;42(4):695–710.

12. McPhillips A., Wolford L.M., Rodrigues D.B. SAPHO syndrome with TMJ involvement: review of the literature and case presentation. Int. J. Oral. Maxillofac. Surg. 2010;39(12):1160–67.

13. Sonozaki H., Mitsui H., Miyanaga Y., Okitsu K., Igarashi M., Hayashi Y., Matsuura M., Azuma A., Okai K., Kawashima M. Clinical features of 53 cases with pustulotic arthro-osteitis. Ann. Rheum. Dis. 1981;40(6):547–53.

14. Colina M., Govoni M., Orzincolo C., Trotta F. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum. 2009;61(6):813–21.

15. Salles M., Olive A., Perez-Andres R., Holgado S., Mateo L., Riera E., Tena X. The SAPHO syndrome: a clinical and imaging study. Clin. Rheumatol. 2011;30(2):245–49.

16. Matsuoka Y., Okada N., Yoshikawa K. Familial Cases of Psoriasis Vulgaris and Pustulosis Palmaris et Plantaris. J. Derm. 1993;20(5):308–10.

17. Freyschmidt J., Sternberg A. The bullhead sign: scintigraphic pattern of sternocostoclavicular hyperostosis and pustulotic arthroosteitis. Eur. Radiol. 1998;8(5):807–12.

18. Patel C.N., Smith J.T., Rankine J.J., Scarsbrook A.F. F-18 FDG PET/CT can help differentiate SAPHO syndrome from suspected metastatic bone disease. Clin. Nucl. Med. 2009;34(4):254–57.

19. Haydar A.A., Gikas P., Saifuddin A. Chronic recurrent multifocal osteomyelitis: a case report and role of whole-body MRI. Clinica.l Radiology. 2009;64(6):641–44.

20. Jung J., Molinger M., Kohn D., Schreiber M., Pfreundschuh M., Assmann G. Intra-articular glucocorticosteroid injection into sternocostoclavicular joints in patients with SAPHO syndrome. Semin. Arthritis Rheum. 2012;42(3):266–70.

21. Assmann G., Simon P. The SAPHO syndrome – are microbes involved? Best Pract. Res. Clin. Rheumatol. 2011;25(3):423–34.

22. Delattre E., Guillot X., Godfrin-Valnet M., Prati C., Wendling D. SAPHO syndrome treatment with intravenous pamidronate. Retrospective study of 22 patients. Joint Bone Spine. 2014;81(5):456–58.

23. Fioravanti A., Cantarini L., Burroni L., Mazzei M. A., Volterrani L., Galeazzi M. Efficacy of alendronate in the treatment of the SAPHO syndrome. J. Clin. Rheumatol. 2008;14(3):183–84.

24 Soyfoo M.S., Gangji V., Margaux J. Successful treatment of SAPHO syndrome with ibandronate. J. Clin. Rheumatol. 2010;16(5):253.

25. Kopterides P., Pikazis D., Koufos C. Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum. 2004;50(9):2970–73.

26. Galadari H., Bishop A.G., Venna S.S., Sultan E., Do D., Zeltser R. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome treated with a combination of isotretinoin and pamidronate. J. Am. Acad. Dermatol. 2009;61(1):123–25.

27. Moll C., Hernandez M.V., Canete J.D., Gomez-Puerta J.A., Soriano A., Collado A., Sanmarti R. Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature. Semin. Arthritis Rheum. 2008;37(5):299–306.

28. Sabugo F., Liberman C., Niedmann J.P., Soto L., Cuchacovich M. Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism. Clin. Rheumatol. 2008;27(4):533–35.

29. Witt M., Meier J., Hammitzsch A., Proft F., Schulze-Koops H., Grunke M. Disease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany: results from a nationwide patient survey. Semin. Arthritis Rheum. 2014;43(6):745–50.

30. Sáez-Martín L.-C., Gómez-Castro S., Román-Curto C., Palacios-Álvarez I., Fernández-López E. Etanercept in the treatment of SAPHO syndrome. Inter. J. Dermatol. 2015;54(6):206–8.

31. Castellvi I., Bonet M., Narvaez J.A., Molina-Hinojosa J.C. Successful treatment of SAPHO syndrome with adalimumab: a case report. Clin. Rheumatol. 2010;29(10):1205–207.

32. Firinu D., Garcia-Larsen V., Manconi P.E., Del Giacco S.R. SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment. Curr. Rheumatol. Rep. 2016;18(6):35.

33. Colina M., Pizzirani C., Khodeir M., Falzoni S., Bruschi M., Trotta F., Di Virgilio F. Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra. Rheumatology (Oxford). 2010;49(7):141618.

34. Wendling D., Aubin F., Verhoeven F., Prati C. IL-23/Th17 targeted therapies in SAPHO syndrome. A case series. Joint Bone Spine. 2017

35. Wendling D., Prati C., Aubin F. Anakinra treatment of SAPHO syndrome: short-term results of an open study. Ann. Rheum. Dis. 2012;71(6):1098–100.


Об авторах / Для корреспонденции


Автор для связи: П.И. Новиков – зав. ревматологическим отделением УКБ № 3, ассистент кафедры внутренних, профессиональных болезней и пульмонологии МПФ ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва; e-mail: novikov-pavel@mail.ru


Бионика Медиа